A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration-resistant Prostate Cancer: Canadian Cancer Trials Group Study IND205.
Sebastien J Hotte , Kim N Chi , Anthony M Joshua , Donsheng Tu
Clinical Genitourinary Cancer 17 ( 3) 201
6
2019
Gemcitabine Plus Cisplatin, an Active Regimen in Advanced Urothelial Cancer: A Phase II Trial of the National Cancer Institute of Canada Clinical Trials Group
Malcolm J. Moore , Eric W. Winquist , Nevin Murray , Ian F. Tannock
Journal of Clinical Oncology 17 ( 9) 2876 -2876
201
1999
Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non–Small-Cell Lung Cancer
Chang-Qi Zhu , Keyue Ding , Dan Strumpf , Barbara A. Weir
Journal of Clinical Oncology 28 ( 29) 4417 -4424
352
2010
Venous Thromboembolism and Non-Small Cell Lung Cancer: A Pooled Analysis of National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) Trials.
Lisa Hicks , Matthew Cheung , Baktiar Hasan , Keyue Ding
Blood 110 ( 11) 3995 -3995
2007
Randomized Phase III Study of Matrix Metalloproteinase Inhibitor BMS-275291 in Combination With Paclitaxel and Carboplatin in Advanced Non-Small-Cell Lung Cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18
Natasha B Leighl , Luis Paz-Ares , Jean-Yves Douillard , Christian Peschel
Journal of Clinical Oncology 23 ( 12) 2831 -2839
141
2005
A Phase II Study of AT7519M, a CDK Inhibitor, in Patients with Chronic Lymphocytic Leukemia: NCIC CTG Trial IND.193
Matthew D. Seftel , John Kuruvilla , Versha Banerji , Graeme Fraser
Blood 124 ( 21) 5670 -5670
1
2014
Need for Global Partnership in Cancer Care: Perceptions of Cancer Care Researchers Attending the 2010 Australia and Asia Pacific Clinical Oncology Research Development Workshop
H. Kim Lyerly , Amy P. Abernethy , Martin R. Stockler , Bogda Koczwara
Journal of Oncology Practice 7 ( 5) 324 -329
11
2011
Abstract CT131: A randomized (RCT) phase II study of oncolytic reovirus (pelareorep ) plus standard weekly paclitaxel (P) as therapy for metastatic breast cancer (mBC)
Vanessa Bernstein , Susan Ellard , Susan F. Dent , Karen A. Gelmon
Cancer Research 77
2
2017
Pooled Analysis of the Prognostic and Predictive Effects of KRAS Mutation Status and KRAS Mutation Subtype in Early-Stage Resected Non–Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy
Frances A Shepherd , Caroline Domerg , Pierre Hainaut , Pasi A Jänne
Journal of Clinical Oncology 31 ( 17) 2173 -2181
188
2013
Role of the total mutation burden (TMB) and tumor-infiltrating lymphocytes (TILs) on the development of second primary cancer after complete resection of non-small cell lung cancer (NSCLC).
Marie-Pier Gauthier , Maryam Karimi , Stefan Michiels , Lesley Seymour
Journal of Clinical Oncology 38 ( 15_suppl) e21092 -e21092
2020
Prognostic and predictive effect of KRAS gene copy number and mutation status in early stage non-small cell lung cancer (NSCLC) patients.
Andrea S. Fung , Maryam Karimi , Stefan Michiels , Lesley Seymour
Journal of Clinical Oncology 38 ( 15_suppl) e21080 -e21080
2020
A Phase Ib Trial of Durvalumab in Combination with Trastuzumab in HER2‐Positive Metastatic Breast Cancer (CCTG IND.229)
Stephen Chia , Phillipe L Bedard , John Hilton , Eitan Amir
Oncologist 24 ( 11) 1439 -1445
36
2019
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
Jedd D Wolchok , Marcus Ballinger , Caroline Caramella , Elisabeth G E de Vries
The Lancet Oncology 18 ( 3) e143 -e152
759
2017
RECIST - learning from the past to build the future.
Saskia Litière , Sandra Collette , Elisabeth G. E. de Vries , Lesley Seymour
Nature Reviews Clinical Oncology 14 ( 3) 187 -192
97
2017
O-58 Quality of life in a trial of adjuvant chemotherapy for early stage completely resected non-small cell lung cancer (NCIC CTG BR.10)
Andrea Beziak , Tim Winton , Keyue Ding , Barbara Graham
Lung Cancer 41 S20
4
2003
Clinical Utility of Epidermal Growth Factor Receptor Expression for Selecting Patients with Advanced Non-small Cell Lung Cancer for Treatment with Erlotinib
Gary M. Clark , Denni M. Zborowski , Jennifer L. Culbertson , Marlo Whitehead
Journal of Thoracic Oncology 1 ( 8) 837 -846
74
2006
Adjuvant Cisplatin and Vinorelbine for Completely Resected Non-small Cell Lung Cancer: Subgroup Analysis of the Lung Adjuvant Cisplatin Evaluation
Jean-Yves Douillard , Hélène Tribodet , Delphine Aubert , Frances A. Shepherd
Journal of Thoracic Oncology 5 ( 2) 220 -228
147
2010
The influence of sex on efficacy, adverse events, quality of life, and delivery of treatment in National Cancer Institute of Canada Clinical Trials Group non-small cell lung cancer chemotherapy trials.
Paul Wheatley-Price , Aurélie Le Maître , Keyue Ding , Natasha Leighl
Journal of Thoracic Oncology 5 ( 5) 640 -648
11
2010
Prognostic and Predictive Value of Epidermal Growth Factor Receptor Tyrosine Kinase Domain Mutation Status and Gene Copy Number for Adjuvant Chemotherapy in Non-small Cell Lung Cancer
Ming-Sound Tsao , Akira Sakurada , Keyue Ding , Sarit Aviel-Ronen
Journal of Thoracic Oncology 6 ( 1) 139 -147
61
2011
Brief Report: A Phase II Study of Sunitinib in Malignant Pleural Mesothelioma. The NCIC Clinical Trials Group
Scott A. Laurie , Ashish Gupta , Quincy Chu , Christopher W. Lee
Journal of Thoracic Oncology 6 ( 11) 1950 -1954
56
2011